2.59 CME

Lacunes en matière de soins dans le traitement du cancer en Inde

Conférencier: Dr GV Nagarjuna Reddy

Head & Neck Oncosurgeon, Ex-Tata Memorial Hospitals, Mumbai.

Connectez-vous pour commencer

Description

The care gap in cancer treatment in India is significant, characterized by disparities in access to early diagnosis and advanced therapies. Rural areas face a severe shortage of oncology specialists and diagnostic facilities, leading to delayed treatment and poorer outcomes. High costs of cancer care also limit access for many patients, particularly in lower-income groups. Additionally, public awareness about cancer prevention and early signs remains low, further exacerbating the problem. Bridging this care gap requires a comprehensive approach, including improving healthcare infrastructure, increasing public awareness, and making treatments more affordable.

Résumé

  • India faces a significant cancer burden, with estimates suggesting approximately 14.6 lakh new cases in 2022 and projections indicating a doubling by 2030 or 2040. The incidence rate is approximately 100.4 per lakh population, highlighting a concerning prevalence. Non-communicable diseases, including cancer, contribute significantly to mortality, driven largely by alcohol and tobacco use, followed by physical inactivity and other factors.
  • Challenges within the Indian cancer care system include a shortage of specialized medical personnel, particularly in public tertiary hospitals. Furthermore, less than half of these hospitals have adequate stocks of essential cancer-treating medications. The comprehensive care journey extends beyond medical interventions, encompassing emotional and mental well-being support for both patients and their families throughout and after treatment.
  • India's cancer incidence is notably high, particularly in comparison to other endemic regions like Brazil. While mortality rates are decreasing for communicable diseases, cancer deaths have increased, reflecting a concerning trend. Certain cancer types, such as head and neck cancers, exhibit disproportionately high mortality rates, potentially due to delayed detection and inadequate access to treatment.
  • Treatment options encompass surgery, chemotherapy, and radiation therapy, among others. Cost remains a major barrier to access, influencing treatment decisions based on affordability within public, charitable, or private healthcare settings. The average cost of cancer treatment varies significantly between public and private facilities, potentially creating disparities in access to appropriate care.
  • Key challenges in cancer treatment include the high prevalence of tobacco use and limited access to healthcare infrastructure, especially in rural areas. Rural populations experience higher cancer mortality rates due to accessibility issues. A significant proportion of healthcare expenditure is out-of-pocket, leading to financial strain and potential impoverishment.
  • Disparities exist in the distribution of healthcare facilities, with a disproportionate concentration in certain regions despite higher cancer incidence in others. The shortage of oncologists is a critical concern, with individual oncologists managing a substantial caseload. Delayed diagnosis and late-stage presentation significantly increase treatment costs and worsen outcomes.
  • Gaps in patient journeys involve delays in accessing care, stemming from a lack of awareness and screening programs. The absence of reliable information sources, coupled with inefficiencies in hospital processes and high treatment costs, further complicate the situation. Post-treatment care and addressing the psychological burden of cancer are often inadequate.
  • Addressing the cancer burden requires multifaceted actions, including promoting awareness and prevention, improving early detection through robust screening programs, and enhancing the capacity of healthcare professionals. Standardized data collection, customized policies, public-private partnerships, and indigenous drug production are critical components of effective cancer control strategies.
  • Strengthening anti-tobacco laws, universalizing HPV vaccination, regulating alcohol consumption, and providing adequate incentives and training for healthcare workers are essential policy interventions. Identifying national brand ambassadors to promote cancer screening and prevention can significantly impact public awareness. Policy changes, budgetary allocations, and effective implementation of existing health schemes are crucial for enhancing the efficiency of cancer care and reducing inequalities.
  • Tackling challenges faced by rural healthcare providers involves improving referral systems and ensuring early suspicion and detection of cancer. The availability of palliative care varies across regions, necessitating expansion to every district to provide dignified end-of-life care. Overcoming barriers to advanced therapies includes addressing budget constraints, promoting indigenous equipment manufacturing, and decentralizing cancer care services through hub-and-spoke models.

Commentaires